Dr Kenneth Savin, Redwire | Groundbreaking ISS Biotech Discoveries
Release Date: 08/04/2025
From Space Force to Patient Advocate | David Beck, MBA
reGEN Podcast
This episode of the reGEN Podcast features United States Space Force veteran David Beck, MBA, and his journey from government and national security roles to serving as a patient advocate and cancer survivor. With over 30 years of experience in the industry, Beck leads Space Technology Ltd., an innovative company operating at the intersection of national security and commercial innovation in the evolving global space economy. Beck’s dedication to the global space industry reflects his commitment to innovation, strategic collaboration and advancing the future of space through...
info_outline
Innovative Cancer Stem Cell Therapies | Andreas Trumpp, PhD
reGEN Podcast
Professor Andreas Trumpp, PhD, discusses his innovative and breakthrough findings from stem cells in leukemia to neuronal interactions in pancreatic cancer. Since 2008, Trumpp has led the Stem Cells and Cancer division at the German Cancer Research Center (DKFZ). In 2008, he became the founding director of the Stem Cell Institute HI-STEM. He is also the coordinator of the Research Program A, Cell and Tumor Biology at the DKFZ and co-director of the DKFZ-ZMBH Alliance. Trumpp’s lab explores the principles of normal and malignant stem cell function, as well as mechanisms...
info_outline
Stem Cells, Space and Cardiovascular Biology | Arun Sharma, PhD
reGEN Podcast
Our conversation with Arun Sharma, PhD, discusses his work as a stem cell biologist, focusing on cardiovascular biology and space biosciences. He is an associate professor at Cedars-Sinai and is affiliated with the Board of Governors Regenerative Medicine Institute, the Smidt Heart Institute and the Cancer Institute and the Department of Biomedical Sciences. He is the director of the Center for Space Medicine Research and the director of the CIRM (California Institute for Regenerative Medicine) Shared Resources Laboratory at Cedars-Sinai. Sharma also co-hosts The Stem Cell Podcast. Research in...
info_outline
Stem Cells and Neurological Applications | Jennifer Graves, MD, PhD
reGEN Podcast
This episode of the reGEN Podcast features our conversation with Jennifer Graves, MD, PhD, who serves as a clinical professor of neurosciences and as a clinical trial expert with the Sanford Stem Cell Clinical Center Alpha Clinic at UC San Diego. Her work includes a focus on Multiple Sclerosis and emerging therapeutic applications for this and other neurological conditions with stem cells and regenerative medicine. Graves oversees active clinical trials at the UC San Diego Alpha Clinic for MS and is a prolific published researcher. Hosted by Bobby Gordon, MA, MBA This episode was recorded on...
info_outline
Sanford Stem Cell Clinical Center | Sheldon Morris, MD, MPH
reGEN Podcast
This episode features Sheldon Morris, MD, MPH, and an overview of the Sanford Stem Cell Clinical Center where Morris serves as director. The Clinical Center at UC San Diego encompasses a wide scope of services and outreach, including the California Institute for Regenerative Medicine (CIRM) Alpha Clinic, clinical trials, community engagement, CIRM grant application assistance and management. We discuss the importance of the collaborative nature of the Clinical Center partnering with trial experts from UC San Diego Health, industry leaders and other researchers for novel discoveries and...
info_outline
A Conversation with CIRM's President and CEO | Jonathan Thomas, PhD, JD
reGEN Podcast
This episode features our conversation with Jonathan Thomas, PhD, JD, President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the chair of the CIRM governing board from June 2011 to March 2023 and has played an integral role in supporting patient-centric research, strategies and outcomes within the Alpha Clinic network and UC San Diego’s Sanford Stem Cell Institute. We discuss his history with CIRM and the impact the organization has had across California. Thomas has a long-standing commitment to patient advocacy. He spent more than 15 years on...
info_outline
Stem Cells and Cancer, In Vivo Discoveries
reGEN Podcast
Our conversation with Tannishtha Reya, PhD, reviews her work and publications on understanding the mechanisms that drive cancer initiation, progression, and therapy resistance. Her research also includes developing high resolution in vivo imaging approaches to map normal stem cell behavior and interactions within a living organism, to define how these change during cancer formation. Tannishtha is the associate director for Translational Research and director of the Irving Drug Discovery Program at Columbia’s Herbert Irving Comprehensive Cancer Center. She is also a former professor with the...
info_outline
Novel Therapeutics and Discoveries | Leo D. Wang, MD, PhD
reGEN Podcast
Our conversation with Leo D. Wang, MD, PhD, includes unique insights into novel discoveries and therapeutics for HIV, diabetes, cancer and other conditions. As the director of the City of Hope Alpha Clinic, we discuss the innovative and collaborative nature of the California Institute for Regenerative Medicine (CIRM) Alpha Clinic network. The City of Hope was the first of now nine CIRM Alpha Clinics, designed to improve patient access to stem cell and regenerative medicine clinical trials for all Californians. Leo Wang also serves as an associate professor in the Departments of...
info_outline
Medical Resilience in Space | Dana Levin, MD, MPH
reGEN Podcast
Dana Levin, MD, MPH, serves as the director of Space Medicine for Vast. As the International Space Station plans for decommission in 2030, Vast is an industry pioneer with developing the first commercial space station, Haven-1, for long-term human habitation of low Earth orbit. We discuss the implications of humans inhabiting space in this new frontier of opportunities, challenges, questions and implications for human health and medicine. Dana’s background before his role at Vast includes working for NASA as a clinical scientist for the human research program, developing methods to assess...
info_outline
The Intersection of AI and Medicine | Bruce Y. Lee, MD, MBA
reGEN Podcast
Our conversation this week is with Bruce Y. Lee, MD, MBA, a digital health and AI expert whose research focuses on AI systems modeling and other computer-aided approaches within the healthcare industry. Bruce has founded, built, and led multiple initiatives in systems science, AI, mathematical and computer modeling, digital health, operations research and science/health communications, including research consortia, centers at universities and independent companies. Hosted by Bobby Gordon, MA, MBA This episode was recorded on Oct. 15, 2025, and information presented herein is current at the...
info_outlineThis episode features our conversation with Dr Kenneth A. Savin, Chief Scientist at Redwire. Dr. Savin was named to TIME’s “2025 TIME100 Health List of the 100 Most Influential People in Global Health.” We discuss his 20-plus year career and expertise in the pharmaceutical industry and his pioneering work accelerating cutting-edge space biotech research capabilities, leveraging microgravity to improve human health on Earth. At Redwire, Dr. Savin has overseen trailblazing investigations onboard the International Space Station (ISS) in partnership with NASA and the ISS National Laboratory. Redwire successfully bioprinted the first human knee meniscus and first live human cardiac tissue using its BioFabrication Facility on the ISS. These breakthroughs address challenges faced by millions of people worldwide through the application of organ transplantation and tissue therapy and advance the next generation of pharmaceutical therapies. Dr. Savin has coordinated groundbreaking protein crystallization investigations onboard the ISS with pharmaceutical companies like Eli Lilly and Company (Lilly) and Bristol Myers Squibb using Redwire’s in-space pharmaceutical lab, PIL-BOX, for improved drug development. These investigations have focused on various applications to address the world’s most prevalent conditions, including antiviral, antifungal, and antiseizure applications, heart disease, and bone loss.
Hosted by Bobby Gordon, MA, MBA.
This episode was recorded on December 2, 2024, and information presented in this episode is current as of this date.